Sign In
Buy INSM
$106.92
-0.490 (-0.456%)
At Close: Jul 24, 2026
Insmed Incorporated (INSM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
08:16pm, Monday, 12'th Jan 2026
Insmed Incorporated (INSM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Insmed CEO Will Lewis talks its rare disease drug pipeline
06:14pm, Monday, 12'th Jan 2026
Will Lewis, Insmed CEO, joins 'Fast Money' to talk the rare disease pipeline, acquisitions in the pharma space, and more.
INSM Stock Jumps on 2025 Preliminary Sales, 2026 Goals Announced
10:36am, Monday, 12'th Jan 2026
Shares of Insmed rise after it tops FY25 sales forecasts, led by strong Brinsupri uptake, and outlines 2026 guidance and pipeline milestones.
Insider Selling: Insmed (NASDAQ:INSM) CFO Sells $293,767.46 in Stock
05:58am, Sunday, 11'th Jan 2026
Insmed, Inc. (NASDAQ: INSM - Get Free Report) CFO Sara Bonstein sold 1,678 shares of the stock in a transaction dated Wednesday, January 7th. The shares were sold at an average price of $175.07, for a
Insmed (NASDAQ:INSM) CFO Sells $252,023.99 in Stock
05:20am, Sunday, 11'th Jan 2026
Insmed, Inc. (NASDAQ: INSM - Get Free Report) CFO Sara Bonstein sold 1,447 shares of the stock in a transaction on Thursday, January 8th. The shares were sold at an average price of $174.17, for a tot
Insider Selling: Insmed (NASDAQ:INSM) Insider Sells $183,401.01 in Stock
05:20am, Sunday, 11'th Jan 2026
Insmed, Inc. (NASDAQ: INSM - Get Free Report) insider Michael Alexander Smith sold 1,053 shares of the business's stock in a transaction on Thursday, January 8th. The stock was sold at an average pric
Insmed (NASDAQ:INSM) COO Sells $247,688.57 in Stock
05:20am, Sunday, 11'th Jan 2026
Insmed, Inc. (NASDAQ: INSM - Get Free Report) COO Roger Adsett sold 1,429 shares of the firm's stock in a transaction that occurred on Tuesday, January 6th. The stock was sold at an average price of $
Insmed (NASDAQ:INSM) CFO Sells $262,941.61 in Stock
05:20am, Sunday, 11'th Jan 2026
Insmed, Inc. (NASDAQ: INSM - Get Free Report) CFO Sara Bonstein sold 1,517 shares of Insmed stock in a transaction dated Tuesday, January 6th. The shares were sold at an average price of $173.33, for
Insmed (NASDAQ:INSM) Insider Sells $241,968.68 in Stock
05:20am, Sunday, 11'th Jan 2026
Insmed, Inc. (NASDAQ: INSM - Get Free Report) insider Michael Alexander Smith sold 1,396 shares of the business's stock in a transaction on Tuesday, January 6th. The shares were sold at an average pri
Insmed Maps Aggressive 2026 As Newly Approved Lung Disease Drug Gains Traction, Pipeline Advances
10:58am, Friday, 09'th Jan 2026
Insmed Inc (NASDAQ: INSM) on Friday outlined a commercial and clinical roadmap for 2026, highlighting strong momentum from its respiratory portfolio and a series of upcoming trial readouts and launche
Insmed Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
07:00am, Friday, 09'th Jan 2026
— BRINSUPRI® (brensocatib) Unaudited Total Revenues of Approximately $144.6 Million for First Full Quarter of Launch; Approximately $172.7 Million for Full-Year 2025— —ARIKAYCE® (amikacin
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
10:00am, Thursday, 08'th Jan 2026
NEW YORK, Jan. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Insmed Incorporated ("Insmed" or the "Company") (NASDAQ: INSM). Such investors are advised to co
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
11:48am, Tuesday, 06'th Jan 2026
NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Insmed Incorporated (“Insmed” or the “Company”) (NASDAQ: INSM). Such investors ar
INSM Stock Up 78% in 6 Months: Here's What You Need to Know
09:15am, Friday, 02'nd Jan 2026
Insmed shares surged on FDA and EU approvals of Brinsupri, strong uptake, and a growing pipeline which fueled optimism around its revenue outlook.
Insmed To Present at the 44th Annual J.P. Morgan Healthcare Conference
07:00am, Friday, 02'nd Jan 2026
BRIDGEWATER, N.J., Jan. 2, 2026 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform
